Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 74

1.

Comparative analysis of graft-versus-host disease prophylaxis with tacrolimus in combination with methylprednisolone or methotrexate after umbilical cord blood transplantation.

Shigemura T, Sakashita K, Okura E, Morita D, Komori K, Kurata T, Hirabayashi K, Saito S, Tanaka M, Yanagisawa R, Nakazawa Y.

Int J Hematol. 2020 Jan 18. doi: 10.1007/s12185-020-02826-9. [Epub ahead of print]

PMID:
31953722
2.

Prophylactic piperacillin administration in pediatric patients with solid tumors following different intensities of chemotherapy.

Saito S, Yanagisawa R, Minami K, Uchida E, Watanabe T, Komori K, Kurata T, Nakamura T, Sakashita K.

Pediatr Int. 2020 Feb;62(2):158-168. doi: 10.1111/ped.14103.

PMID:
31846519
3.

Complete measurable residual disease response after combination chemotherapy with AML-type and ALL-type regimens in pediatric B/myeloid acute bilineal leukemia.

Saito S, Taira C, Matsuda K, Yanagisawa R, Morita D, Shigemura T, Yoshikawa K, Tanaka M, Sakashita K, Mukai S, Shimodaira S, Koike K, Nakazawa Y.

Leuk Lymphoma. 2020 Apr;61(4):967-970. doi: 10.1080/10428194.2019.1697813. Epub 2019 Dec 6. No abstract available.

PMID:
31809628
4.

A Rapid Cytologic Double Staining of Epstein-Barr Virus-encoded Small RNA and Cell Surface Markers for Diagnosis of Epstein-Barr Virus-associated Hemophagocytic Lymphohistiocytosis.

Takahashi N, Kudo K, Tanaka M, Kumagai N, Sato T, Kamio T, Sasaki S, Terui K, Kurose A, Yanagisawa R, Nakazawa Y, Ito E.

J Pediatr Hematol Oncol. 2019 Nov 14. doi: 10.1097/MPH.0000000000001647. [Epub ahead of print]

PMID:
31743316
5.

In Vivo Administration of Recombinant Human Granulocyte Colony-Stimulating Factor Increases the Immune Effectiveness of Dendritic Cell-Based Cancer Vaccination.

Shimodaira S, Yanagisawa R, Koya T, Hirabayashi K, Higuchi Y, Sakamoto T, Togi M, Kato T Jr, Kobayashi T, Koizumi T, Koido S, Sugiyama H.

Vaccines (Basel). 2019 Sep 19;7(3). pii: E120. doi: 10.3390/vaccines7030120.

6.

Analysis of the clinical characteristics of pediatric patients who experience ifosfamide-induced encephalopathy.

Ide Y, Yanagisawa R, Kubota N, Sakashita K, Tozuka M, Nakamura T, Honda T.

Pediatr Blood Cancer. 2019 Dec;66(12):e27996. doi: 10.1002/pbc.27996. Epub 2019 Sep 18.

PMID:
31535455
7.

Investigation of factors associated with allergic transfusion reaction due to platelet transfusion and the efficacy of platelets resuspended in BRS-A in adult patients.

Yamanaka M, Yanagisawa R, Kojima S, Nakazawa H, Shimodaira S.

Transfusion. 2019 Nov;59(11):3405-3412. doi: 10.1111/trf.15527. Epub 2019 Sep 18.

PMID:
31532542
8.

Analysis of clinical presentations of allergic transfusion reactions and febrile non-haemolytic transfusion reactions in paediatric patients.

Yanagisawa R, Tatsuzawa Y, Ono T, Kobayashi J, Tokutake Y, Hidaka E, Sakashita K, Nakamura T.

Vox Sang. 2019 Nov;114(8):826-834. doi: 10.1111/vox.12833. Epub 2019 Aug 28.

PMID:
31463954
9.

Prevention of transfusion-transmitted cytomegalovirus infection using leukoreduced blood components in patients receiving seronegative umbilical cord blood transplantation.

Shigemura T, Yanagisawa R, Komori K, Morita D, Kurata T, Tanaka M, Sakashita K, Nakazawa Y.

Transfusion. 2019 Oct;59(10):3065-3070. doi: 10.1111/trf.15456. Epub 2019 Jul 19.

PMID:
31322734
10.

Correction to: Factors predicting the recurrence of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in children after treatment using the HLH-2004 protocol.

Yanagisawa R, Matsuda K, Ohga S, Kanegane H, Morimoto A, Okamoto Y, Ohara A, Fukushima K, Sotomatsu M, Nomura K, Saito AM, Horibe K, Ishii E, Nakazawa Y.

Int J Hematol. 2019 May;109(5):629. doi: 10.1007/s12185-019-02641-x.

PMID:
30977106
11.

Ovarian function after allogeneic hematopoietic stem cell transplantation in children and young adults given 8-Gy total body irradiation-based reduced-toxicity myeloablative conditioning.

Komori K, Hirabayashi K, Morita D, Hara Y, Kurata T, Saito S, Tanaka M, Yanagisawa R, Sakashita K, Koike K, Nakazawa Y.

Pediatr Transplant. 2019 May;23(3):e13372. doi: 10.1111/petr.13372. Epub 2019 Feb 3.

PMID:
30714283
12.

Outcomes in children with hemophagocytic lymphohistiocytosis treated using HLH-2004 protocol in Japan.

Yanagisawa R, Nakazawa Y, Matsuda K, Yasumi T, Kanegane H, Ohga S, Morimoto A, Hashii Y, Imaizumi M, Okamoto Y, Saito AM, Horibe K, Ishii E; HLH/LCH committee members of the Japan Children’s Cancer Group.

Int J Hematol. 2019 Feb;109(2):206-213. doi: 10.1007/s12185-018-02572-z. Epub 2018 Dec 7.

PMID:
30535855
13.

Comparison of administration of platelet concentrates suspended in M-sol or BRS-A for pediatric patients.

Kojima S, Yanagisawa R, Tanaka M, Nakazawa Y, Shimodaira S.

Transfusion. 2018 Dec;58(12):2952-2958. doi: 10.1111/trf.14917. Epub 2018 Oct 6.

PMID:
30291756
14.

Significance of Molecular Monitoring of T Cells for the Decision of Treatment Strategy for Epstein-Barr Virus-associated Hemophagocytic Lymphohistiocytosis.

Saito T, Tanaka M, Matsuda K, Honma H, Komori K, Morita D, Nakazawa H, Yanagisawa R, Nakazawa Y.

J Pediatr Hematol Oncol. 2019 Jul;41(5):407-409. doi: 10.1097/MPH.0000000000001262.

PMID:
30044353
15.

Cisplatin-induced nephrotoxicity in patients with advanced neuroblastoma.

Yanagisawa R, Kubota N, Hidaka E, Sakashita K, Tanaka M, Nakazawa Y, Nakamura T.

Pediatr Blood Cancer. 2018 Sep;65(9):e27253. doi: 10.1002/pbc.27253. Epub 2018 May 24. No abstract available.

PMID:
29797635
16.

Feasibility and Immune Response of WT1 Peptide Vaccination in Combination with OK-432 for Paediatric Solid Tumors.

Hirabayashi K, Yanagisawa R, Saito S, Higuchi Y, Koya T, Sano K, Koido S, Okamoto M, Sugiyama H, Nakazawa Y, Shimodaira S.

Anticancer Res. 2018 Apr;38(4):2227-2234.

PMID:
29599343
17.

WT1-pulsed Dendritic Cell Vaccine Combined with Chemotherapy for Resected Pancreatic Cancer in a Phase I Study.

Yanagisawa R, Koizumi T, Koya T, Sano K, Koido S, Nagai K, Kobayashi M, Okamoto M, Sugiyama H, Shimodaira S.

Anticancer Res. 2018 Apr;38(4):2217-2225.

PMID:
29599342
18.

Transfusion-associated hypoxemia in pediatric patients with solid tumors after autologous peripheral blood stem cell transplantation.

Yanagisawa R, Abe S, Fujihara I, Komori K, Kondo Y, Sakashita K, Nakamura T.

Transfus Apher Sci. 2017 Oct;56(5):744-747. doi: 10.1016/j.transci.2017.09.003. Epub 2017 Sep 20.

PMID:
28965826
19.

Myelomonocytic differentiation associated with NPM1-RARA rearrangement.

Yanagisawa R, Ogiso Y, Yoshikawa K, Tanaka M, Matsuda K, Ishii E.

Br J Haematol. 2017 Oct;179(2):183. doi: 10.1111/bjh.14841. Epub 2017 Jul 12. No abstract available.

PMID:
28699672
20.

Asymptomatic subcutaneous cervical mass due to Actinomyces odontolyticus infection in a pyriform sinus fistula.

Yanagisawa R, Minami K, Kubota N, Iwade T, Ogiso Y.

Pediatr Int. 2017 Aug;59(8):941-942. doi: 10.1111/ped.13321. Epub 2017 Jun 23. No abstract available.

PMID:
28643960

Supplemental Content

Loading ...
Support Center